These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10618547)

  • 1. Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers.
    Baras B; Benoit M; Poulain-Godefroy O; Schacht A; Capron A; Gillard J; Riveau G
    Vaccine; 2000 Feb; 18(15):1495-505. PubMed ID: 10618547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen.
    Baras B; Benoit MA; Dupré L; Poulain-Godefroy O; Schacht AM; Capron A; Gillard J; Riveau G
    Infect Immun; 1999 May; 67(5):2643-8. PubMed ID: 10225935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles.
    Vordermeier HM; Coombes AG; Jenkins P; McGee JP; O'Hagan DT; Davis SS; Singh M
    Vaccine; 1995 Nov; 13(16):1576-82. PubMed ID: 8578845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles.
    Kim SY; Doh HJ; Ahn JS; Ha YJ; Jang MH; Chung SI; Park HJ
    Vaccine; 1999 Feb; 17(6):607-16. PubMed ID: 10075169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
    Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E
    Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Lavelle EC; Yeh MK; Coombes AG; Davis SS
    Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibody responses elicited in mice immunized with recombinant bacillus Calmette-Guérin producing the Schistosoma mansoni glutathione S-transferase.
    Kremer L; Riveau G; Baulard A; Capron A; Locht C
    J Immunol; 1996 Jun; 156(11):4309-17. PubMed ID: 8666802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat-killed Propionibacterium acnes augment the protective effect of 28-kDa glutathione S-transferases antigen against Schistosoma mansoni infection.
    Lam HYP; Yang TH; Liang TR; Cheng PC; Chang KC; Peng SY
    Acta Trop; 2021 Oct; 222():106033. PubMed ID: 34224719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable poly (DL-lactide glycolide) microparticles as a vehicle for allergen-specific vaccines: a study performed with Ole e 1, the main allergen of olive pollen.
    Batanero E; Barral P; Villalba M; Rodríguez R
    J Immunol Methods; 2002 Jan; 259(1-2):87-94. PubMed ID: 11730844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.
    Singh M; Li XM; Wang H; McGee JP; Zamb T; Koff W; Wang CY; O'Hagan DT
    Infect Immun; 1997 May; 65(5):1716-21. PubMed ID: 9125552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization.
    Marazuela EG; Prado N; Moro E; Fernández-García H; Villalba M; Rodríguez R; Batanero E
    Clin Exp Allergy; 2008 Mar; 38(3):520-8. PubMed ID: 18205856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity.
    Murillo M; Gamazo C; Irache JM; Goñi MM
    J Drug Target; 2002 May; 10(3):211-9. PubMed ID: 12075822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration.
    Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL
    Pharm Res; 2004 Jan; 21(1):121-6. PubMed ID: 14984266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
    Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
    Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium.
    Kremer L; Dupré L; Riveau G; Capron A; Locht C
    Infect Immun; 1998 Dec; 66(12):5669-76. PubMed ID: 9826340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres.
    Johansen P; Estevez F; Zurbriggen R; Merkle HP; Glück R; Corradin G; Gander B
    Vaccine; 2000 Dec; 19(9-10):1047-54. PubMed ID: 11137238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
    Delgado A; Lavelle EC; Hartshorne M; Davis SS
    Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles.
    Singh M; Shirley B; Bajwa K; Samara E; Hora M; O'Hagan D
    J Control Release; 2001 Jan; 70(1-2):21-8. PubMed ID: 11166404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japanese encephalitis virus vaccine formulations using PLA lamellar and PLG microparticles.
    Yeh MK; Coombes AG; Chen JL; Chiang CH
    J Microencapsul; 2002; 19(5):671-82. PubMed ID: 12433308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers.
    Yan C; Rill WL; Malli R; Hewetson J; Tammariello R; Kende M
    Vaccine; 1995 May; 13(7):645-51. PubMed ID: 7668034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.